A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study

CBC - Oct 23, 2026

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.

Read full article

More News

Voyage Times

Voyage Times publishes travel and lifestyle articles for travelers and culture hunter from around the world. Discover the places that you haven't heard of here.

NEWSLETTER

Copyright © 2015 - 2026 Voyage Times. All Rights Reserved.